Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Reviva Pharmaceuticals Holdings, Inc. publishes a filing, an earnings call transcript or a press release.

Get RVPH alerts

About Laxminarayan Bhat

Laxminarayan Bhat is recorded as Board Member at Reviva Pharmaceuticals Holdings, Inc. (RVPH) since January 1, 2020 and CEO at Reviva Pharmaceuticals Holdings, Inc. (RVPH). The newest filing on record that lists Laxminarayan Bhat as CEO and Board Member at Reviva Pharmaceuticals Holdings, Inc. (RVPH) is dated November 9, 2026. The proxy statement of Reviva Pharmaceuticals Holdings, Inc. reports total compensation of $1,442,121 for Laxminarayan Bhat in fiscal 2025, including a base salary of $565,000. Disclosed compensation is on record for 7 fiscal years. Laxminarayan Bhat has spoken on 2 investor events across 1 company, most recently for Reviva Pharmaceuticals Holdings, Inc. on September 29, 2026. Reviva Pharmaceuticals Holdings, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Reviva Pharmaceuticals Holdings, Inc. includes Parag Saxena (Chairman), Narayan Prabhu (CFO), Les Funtleyder (Board Member) and 3 others.

Laxminarayan Bhat on recent calls

“Before I start my presentation, I would like you all to view the forward-looking statements displayed here. So, in this presentation, I would like to give a brief overview of what we do here at Reviva.”
CEO, Lytham Partners Fall 2026 Investor Conference ·
“I really appreciate the opportunity to present here at lithium conference and then looking forward to connecting the viewers and then investors in this conference so before i begin my presentation i would like all the viewers to take a look at our forward-looking statements displayed here so i'll give a very brief…”
CEO, Lytham Partners Spring 2026 Investor Conference ·

Affiliation history

Company network

Leadership on record at Reviva Pharmaceuticals Holdings, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Reviva Pharmaceuticals Holdings, Inc. (RVPH) $565,000 $1,442,121
2024 Reviva Pharmaceuticals Holdings, Inc. (RVPH) $450,000 $607,500
2023 Reviva Pharmaceuticals Holdings, Inc. (RVPH) $450,000 $2,764,747
2022 Reviva Pharmaceuticals Holdings, Inc. (RVPH) $400,000 $560,000
2021 Reviva Pharmaceuticals Holdings, Inc. (RVPH) $400,000 $600,054
2020 Reviva Pharmaceuticals Holdings, Inc. (RVPH) $247,952 $247,952
2019 Reviva Pharmaceuticals Holdings, Inc. (RVPH) $240,000 $240,000

Recent activity